TG Therapeutics Mourns the Loss of Board Member, Mark Schoenebaum, MD
TG Therapeutics, Inc. (TGTX)
Last tg therapeutics, inc. earnings: 11/12 07:34 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.tgtherapeutics.com
Company Research
Source: GlobeNewswire
NEW YORK, Aug. 26, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) announced with great sadness the passing of longtime Board Member, Mark Schoenebaum, MD. "Everyone at TG is incredibly saddened by the loss of Mark Schoenebaum. He was one of our first Directors, joining us in 2012, the year we founded the Company. Mark has been a key member of our team who always provided incredible insight and guidance. His presence will be sorely missed as a great person, a talented board member and a dear friend. We offer our deepest condolences to his family in this difficult time,” stated Michael S. Weiss, the Company's Executive Chairman and Chief Executive Officer. ABOUT TG THERAPEUTICS, INC. TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Currently, the company is developing multiple therapies targeting hematological malignancies and autoimmune d
Show less
Read more
Impact Snapshot
Event Time:
TGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TGTX alerts
High impacting TG Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TGTX
News
- TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Why TG Therapeutics Stock Was Rocketing Higher This Week [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at HC Wainwright from $45.00 to $49.00. They now have a "buy" rating on the stock.MarketBeat
- TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at LADENBURG THALM/SH SH from $39.00 to $40.00. They now have a "buy" rating on the stock.MarketBeat
- TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
TGTX
Earnings
- 5/1/24 - Miss
TGTX
Sec Filings
- 5/6/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 4/29/24 - Form ARS
- TGTX's page on the SEC website